Loading clinical trials...
Loading clinical trials...
A Phase I Study of Vorinostat in Combination With Vincristine, Irinotecan, and Temozolomide in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors and CNS Malignancies
Conditions
Interventions
Vorinostat
Locations
1
United States
New York Medical College
Valhalla, New York, United States
Start Date
March 17, 2017
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2027
Last Updated
April 15, 2026
NCT03715933
NCT06541262
NCT04851119
NCT04322318
NCT05918640
NCT07148050
Lead Sponsor
New York Medical College
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions